首页> 外文期刊>Indian Journal of Chemistry, Section B. Organic Including Medicinal >Model study on the sequence specific stacking by chromophore of an anticancer drug, acridine carboxamide with base pairs of DNA
【24h】

Model study on the sequence specific stacking by chromophore of an anticancer drug, acridine carboxamide with base pairs of DNA

机译:抗癌药物a啶羧酰胺与DNA碱基对的发色团序列特异性堆积模型研究

获取原文
获取原文并翻译 | 示例
           

摘要

The study on the sequence specific binding of acridine-4-carboxamides with DNA has been an important topic in the design of new drugs. It has been known that the anticancer properties of acridine-2, acridine-3 and acridine-4-carboxamides are significantly different. So the sequence specific binding of these drugs can be monitored from the intercalative mode of binding by chromophores within DNA. The stacking energies obtained from ab initio, MP2 and DFT methods have been used to understand the sequence preference intercalation by chromophore. Among these drugs, the acridine-4-carboxamide shows maximum stacking with GC base pair in spite of acquiring high potency, but the stacking energy of this drug with AT base pair is not so small. The conformation of carboxamide side chain in acridine-4-carboxamide does not lie in the same plane of chromophore, and also the orientation of side chain in acridine-2 and acridine-3 carboxamides is different from that of acridine-4-carboxamide.
机译:a啶-4-羧酰胺与DNA序列特异性结合的研究一直是新药设计的重要课题。已知that啶-2,a啶3和a啶-4-羧酰胺的抗癌性质显着不同。因此,这些药物的序列特异性结合可以通过DNA内的发色团从结合的嵌入模式进行监测。从头算,MP2和DFT方法获得的堆积能已用于理解生色团的序列优先插入。在这些药物中,a啶-4-羧酰胺尽管获得了很高的效力,但与GC碱基对的堆积却最大,但是该药物与AT碱基对的堆积能量却不算小。 cr啶-4-羧酰胺中羧酰胺侧链的构象不在发色团的同一平面上,a啶-2和a啶-3羧酰胺中侧链的取向也不同于a啶-4-羧酰胺。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号